GluN2B-Mediated Microglial Activation and Tau Phagocytosis
🧪 Overview
This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance through enhanced phagocytic activity rather than glymphatic drainage. GluN2B subunits (encoded by GRIN2B) are expressed on microglial processes that extend into synaptic clefts and perineuronal spaces, where they respond to pathological glutamate release from tau-burdened neurons. Upon activation, these receptors generate sustained calcium influx that triggers a specific microglial phenotypic switch characterized by upregulation of phagocytic receptors including TREM2, CD68, and complement receptor 3. The calcium-dependent activation of calcineurin dephosphorylates nuclear factor of activated T-cells (NFAT), promoting its nuclear translocation and transcriptional upregulation of genes encoding lysosomal enzymes such as cathepsin D and hexosaminidase A. Simultaneously, GluN2B-mediated calcium signaling activates the mTOR pathway through calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ), enhancing autophagosome formation and fusion with lysosomes. This creates an enhanced degradative capacity specifically targeted toward hyperphosphorylated tau species.
...🧬 Mechanism
Curated pathway from expert analysis
graph TD
A["GluN2B NMDA Receptor<br/>Extrasynaptic Expression"] --> B["Calcium Influx<br/>Ca2+ Permeable Channel"]
B --> C["CaMKII Activation<br/>Calcium-Dependent Kinase"]
C --> D["CREB Phosphorylation<br/>Transcription Factor"]
D --> E["Synaptic Plasticity Genes<br/>LTP Enhancement"]
A --> F["Thalamic Relay Neurons<br/>VB and VPM Nuclei"]
F --> G["Cortical Layer IV<br/>Sensory Input Processing"]
G --> H["Pyramidal Neurons<br/>Layer V Output"]
A --> I["Gamma Oscillations<br/>40-100 Hz Frequency"]
I --> J["Theta Oscillations<br/>4-8 Hz Frequency"]
J --> K["Thalamocortical Synchrony<br/>Network Coordination"]
L["GluN2B Positive Modulator<br/>Therapeutic Intervention"] --> A
L --> M["Enhanced NMDA Function<br/>Prolonged Deactivation"]
M --> N["Sustained Depolarization<br/>Temporal Integration"]
N --> K
O["Neurodegeneration<br/>Pathological State"] --> P["Reduced GluN2B Expression<br/>Receptor Downregulation"]
P --> Q["Disrupted Oscillations<br/>Loss of Synchrony"]
Q --> R["Cognitive Impairment<br/>Functional Outcome"]
classDef normal fill:#4fc3f7,color:#0d0d1a
classDef therapeutic fill:#81c784,color:#0d0d1a
classDef pathology fill:#ef5350,color:#0d0d1a
classDef outcome fill:#ffd54f,color:#0d0d1a
classDef molecular fill:#ce93d8,color:#0d0d1a
class A,B,C,D,E,M,N normal
class L therapeutic
class O,P,Q pathology
class R outcome
class F,G,H,I,J,K molecular⚖️ Evidence
🏥 Translation
🧬 3D Protein Structure — GRIN2B
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for GRIN2B from GTEx v10.
💉 Clinical Trials (8)Relevance: 45%
Active
Completed
Total Enrolled
Highest Phase
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GRIN2B.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |